1. Introduction; 2. Scheduling criteria; 3. Critical review of psychoactive substances; 4. Pre-review of psychoactive substances; 5. Terminology used in reporting abuse-related adverse drug reactions; 6. Other matters; Acknowledgements; References; Annex Terminology used in reporting abuse-related adverse drug reactions; References.
This report presents the recommendations of a WHO Expert Committee responsible for reviewing information on dependence-producing drugs to assess the need for their international control. The first part of the report contains a summary of the Committee's evaluations of seven substances (dronabinol, oripavine, buprenorphine, butorphanol, ketamine, khat and zopiclone). The report also discusses the substances that were pre-reviewed (gamma-hydroxybutyric acid and tramadol) and recommended gamma-hydroxybutyric acid for critical review at a future meeting. Two substances (gamma-butyrolactone and 1,4-butanediol) were identified for future pre-review).